Prevalence of Thyroid Dysfunction and Anti-thyroid Antibodies in Infertile Women
Launched by CAIRO UNIVERSITY · May 24, 2019
Trial Information
Current as of May 13, 2025
Unknown status
Keywords
ClinConnect Summary
The study population will be divided into three groups:
* Group (A) consisting of 40 infertile women with either unexplained or anovulatory infertility with/without associated male factor of infertility,
* Group (B) consisting of 40 infertile women with tubal (mechanical) factor of infertility with/without associated male factor of infertility, and
* Group (C) consisting of 40 women with exclusive male factor of infertility and will be used as a control group.
. All women will be subjected to:
* Informed consent
* Full history taking, including age, duration of infertility and whether p...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • - Age: 18 - 38 years
- • Infertile women whether due to functional, anatomical, male factors OR unexplained OR combined factors
- Exclusion Criteria:
- • - Age: below 18 and above 38 years
- • Patients with autoimmune diseases (such as lupus and rheumatoid arthritis)
- • Acute illness that require hospitalization
- • Patients on the following medications: steroids, dopamine, iodine, amiodarone, lithium, donperidone, thyroid hormone, and phenytoin.
- • Patients who work at night.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Ahmed Maged
Principal Investigator
Professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials